Chronic diseases are the leading cause of death in developed and developing countries[@b1]. These long-term diseases drastically affect the quality of life of afflicted patients and can cause depression of afflicted patients. Indeed, health-related quality of life (physical, psychological status) is increasingly important in people suffering from chronic diseases. According to the World Health Organization[@b2], more than 36 million people in the world are killed by chronic diseases each year, and approximately 80% of these deaths, accounting for 29 million people, are from low- and middle-income countries. The five main types of chronic diseases include cardiovascular and cerebrovascular diseases, chronic respiratory diseases, diabetes, cancers and musculoskeletal disorders[@b2][@b3][@b4]. Given the prevalence of chronic diseases and mental illnesses, the World Economic Forum concluded that the world would sustain a cumulative output loss of \$47 trillion between 2011 and 2030, of which nearly \$30 trillion would be attributable to cardiovascular diseases, chronic pulmonary diseases, diabetes, and cancers[@b4]. Therefore, low-cost, easily accessible, and side effect-free programs must be developed to cure such chronic diseases.

Exercise is generally well accepted as significantly contributing to the prevention and treatment of chronic diseases[@b5]. Traditional Chinese exercise (TCE) is a representative form of exercise that is becoming increasingly popular worldwide for the improvement of health and well-being. TCE such as Tai Chi, Qigong, and Baduanjin does not require the use of equipment, is low in cost and easy to learn[@b6][@b7][@b8]. TCE has been used for 2000 years and is also a promising[@b9], low-risk intervention that can help improve quality of life and alleviate depression in patients with chronic diseases[@b10][@b11][@b12].

TCE includes different types of exercise; the main types are Tai Chi, Qigong, Baduanjin, and Liuzijue, among others. Tai Chi, which is also called "taiji," "taijichuan" or "taijiquan," is a famous form of TCE worldwide. Tai Chi is a type of traditional mind body exercise, that developed as a martial art and a means of self-defense in China. Qigong is a general form of TCE and comprises exercises for postural control, coordinated breathing and meditation. *Qi* refers to vital energy, and *gong* means discipline. Baduanjin translates to the Eight Section Brocades, which refers to eight individual movements for improving general health. Liuzijue is a form of breathing exercise in China that was passed down from ancient times[@b6][@b7][@b8][@b9][@b10][@b11][@b12][@b13]. The practice of TCE usually focuses on a combination of physical and mental exercises.

Most TCE is not only exercise therapy, but also includes meditation field. Because of the meditative aspect, TCE could also improve psychological well-being and reduce stress. According to Chang *et al.*[@b14], TCE (e.g., Tai Chi) is theorized to improve cognition by enhancing brain activation through meditation. In addition, Wayne *et al.*[@b15] had proposed a relationship between Tai Chi and social interaction, and this positive linkage has even extended to brain function. Based upon the model of Chang *et al.*[@b14], TCE could bring positive efficacy in cognition via multiple pathways, including motor function, cardiovascular function, coordination function, social interaction, and meditation.Although TCE is widely performed to prevent and treat chronic diseases, studies on TCE have not reached a consensus with regard to how such exercise can improve the quality of life and alleviate depression in patients with chronic diseases[@b10][@b11][@b12][@b16][@b17]. Similarly, we have yet to find any meta-analysis that has assessed the effect of TCE on the quality of life and depression of patients with chronic diseases. Previous systematic reviews have focused on one type of TCE (such as Tai Chi) for chronic diseases. Therefore, this current meta-analysis aims to identify the effects of TCE on the quality of life and depression of patients with chronic diseases. Additionally, the meta-analysis provides an overall assessment of the effect of TCE on the quality of life and mental health of patients with chronic diseases as well as of the different TCE methods used to treat people with chronic diseases.

Methods
=======

Protocol and registration
-------------------------

The meta-analysis was performed and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) guidelines. The protocol was registered prior to conducting the review. Systematic review registration: <http://www.crd.york.ac.uk/PROSPERO>. PROSPERO registration number: CRD42013006474.

Search strategy
---------------

We searched for relevant studies that were published between January 1957 and January 2015 from several electronic data sources, including PubMed, EMBASE, Web of Science, the Cochrane Library, EBSCO (CINAHL), and China National Knowledge Infrastructure. No language restrictions were employed. The search was limited to randomized controlled trials (RCTs). All of the electronic search strategies for all databases are provided in [Supplementary Table S1](#S1){ref-type="supplementary-material"}.

Inclusion criteria
------------------

Types of studies: We only covered published articles with completed RCTs.Types of participants: We included articles wherein the participants suffered from five main clusters of chronic diseases: cardiovascular and cerebrovascular diseases (e.g., stroke and heart attacks), musculoskeletal disorders (e.g., fibromyalgia), chronic respiratory diseases (i.e., chronic obstructed pulmonary disease), cancers, and diabetes.Types of interventions: We only considered articles that compared an intervention group, in which the members performed TCE (e.g., Tai Chi, Qigong, and Baduanjin), with a control group, in which the members performed another intervention (i.e., strength exercise or drug) or that did not undergo any intervention.Types of outcome measures: The outcome measures were quality of life and depression. Outcomes were recorded for three time periods: short term (less than 3 months), mid term (from 3 months to 12 months) and long term (1 year or more).

Selection of studies
--------------------

Two authors independently used the same selection criteria to screen the titles, abstracts, and bodies of the relevant articles. The studies that failed to meet the inclusion criteria were removed from the sample. In the case of disagreement, the two authors would discuss or consult a third author.

Data extraction and management
------------------------------

The following data were extracted from the selected articles: study characteristics (e.g., author and year), participant characteristics (e.g., age and number of subjects), intervention description, trial period duration, assessed outcomes, and time points. The two authors who selected the studies also extracted the data from the included articles. Any disagreement was resolved through discussion, and a third author was consulted in cases where disagreement persisted.

Quality assessment
------------------

We used the PEDro scale[@b18] to evaluate the risk of bias for inclusion in the meta-analysis. Using a pre-determined 10-item scale, two review authors independently assessed the methodological quality of each study. The following information was evaluated: random allocation, concealed allocation, baseline comparability, blind subjects, blind therapists, blind assessors, adequate follow-up, intention-to-treat analysis, between-group comparisons, point estimates, and variability. The review authors did not evaluate their own studies. A third author was consulted when a disagreement occurred.

Statistical analysis
--------------------

Review Manager software (RevMan5.3) was used to conduct the meta-analysis. The chi-square test and I^2^ statistic were used to evaluate the heterogeneity among the studies. Using a random effects model, the outcome measures from the individual studies were combined through a meta-analysis. If continuous data were reported as the median and within an interquartile range (IQR), the median would be assumed to be equivalent to the mean, and the relationship of the IQR with the standard deviation was roughly SD = IQR/1.35[@b19]. Given that all variables in the included studies were expressed as continuous data, we used the standardized mean difference or the mean difference and the 95% confidence interval (CI) to analyze the studies. We considered p \< 0.05 as statistically significant. Sensitivity analysis was performed by removing each study individually to assess the consistency and quality of the results. Funnel plot asymmetry was employed to assess possible publication bias by Egger's regression test.

Results
=======

Descriptive results
-------------------

The flow chart of the study selection procedure is outlined in [Fig. 1](#f1){ref-type="fig"}. Of the 106 potentially relevant studies that were identified, 46 were excluded for not completing an RCT or for producing irrelevant outcomes. Thus, we included 4311 patients with chronic diseases from the 60 remaining articles[@b20][@b21][@b22][@b23][@b24][@b25][@b26][@b27][@b28][@b29][@b30][@b31][@b32][@b33][@b34][@b35][@b36][@b37][@b38][@b39][@b40][@b41][@b42][@b43][@b44][@b45][@b46][@b47][@b48][@b49][@b50][@b51][@b52][@b53][@b54][@b55][@b56][@b57][@b58][@b59][@b60][@b61][@b62][@b63][@b64][@b65][@b66][@b67][@b68][@b69][@b70][@b71][@b72][@b73][@b74][@b75][@b76][@b77][@b78][@b79] (21 articles focused on musculoskeletal disorders, 16 articles focused on cardiovascular diseases, 14 articles focused on diabetes, 4 articles focused on cancers, 4 articles focused on chronic respiratory diseases, and 1 article focused on chronic physical illnesses). These articles were mainly published in China (n = 21, 35%), USA (n = 15, 25%), Australia (n = 4, 6.67%), Sweden (n = 3, 5%), Korea (n = 3, 5%), Hong Kong (n = 3, 5%), the UK (n = 2, 3.33%), Canada (n = 2, 3.33%), Germany (n = 2, 3.33%), New Zealand (n = 1, 1.67%), Israel (n = 1, 1.67%), and Japan (n = 1, 1.67%). The characteristics of each included study are summarized in [Table 1](#t1){ref-type="table"}.

Methodological quality
----------------------

The methodological quality of all included articles was assessed ([Table 2](#t2){ref-type="table"}). The generation of the allocation sequence was reported in all articles (n = 60, 100%). A total of 15 articles (25%) conducted allocation concealment. A total of 23 articles (38.33%) blinded the outcome assessors to the treatment allocation. A total of 28 articles (46.67%) had an adequate follow-up period. In addition, 13 articles (21.67%) used the intention to treat as their primary analysis method.

Quality of life
---------------

### Short-form (SF-36) survey

Using a random effects model, the meta-analysis of six studies[@b35][@b39][@b49][@b62][@b67][@b76] with 591 patients showed that TCE could improve the total SF-36 score in the short term \[SMD (95% CI) = 0.59 (0.32, 0.87), P \< 0.001\] ([Table 3](#t3){ref-type="table"}) and mid term \[SMD (95% CI) = 0.61 (0.16, 1.05), P = 0.008\] ([Table 3](#t3){ref-type="table"}). The meta-analysis of 22 studies with 1533 patients[@b26][@b27][@b29][@b34][@b35][@b41][@b44][@b46][@b49][@b51][@b52][@b54][@b55][@b56][@b58][@b59][@b63][@b64][@b65][@b76][@b78][@b79] that were suitable for inclusion showed that TCE had a significant positive effect on the SF-36 physical function subscale in the short term \[SMD (95% CI) = 0.35 (0.13, 0.56), P = 0.002\] ([Table 3](#t3){ref-type="table"} and [Fig. 2](#f2){ref-type="fig"}) and mid term \[SMD (95% CI) = 0.49 (0.12, 0.85), P = 0.009\] ([Table 3](#t3){ref-type="table"} and [Fig. 3](#f3){ref-type="fig"}). A total of 22 studies with 1502 patients[@b20][@b27][@b29][@b34][@b35][@b42][@b44][@b46][@b49][@b51][@b52][@b54][@b55][@b56][@b58][@b59][@b63][@b64][@b65][@b76][@b78][@b79] were included to estimate the effect of TCE on the SF-36 mental health subscale. The TCE group outperformed the control group in terms of the SF-36 mental health subscale in the short term (\[SMD (95% CI) = 0.28 (0.11, 0.46), P = 0.002) ([Table 3](#t3){ref-type="table"}, [Supplementary Figure S1](#S1){ref-type="supplementary-material"}) and mid term \[SMD (95% CI) = 0.39 (0.08, 0.71), P = 0.02\] ([Table 3](#t3){ref-type="table"}, [Supplementary Figure S2](#S1){ref-type="supplementary-material"}). No significant difference was observed among the 15 studies with 935 patients[@b20][@b26][@b27][@b29][@b34][@b41][@b46][@b49][@b54][@b55][@b59][@b63][@b65][@b76][@b79] that investigated the SF-36 general health subscale in the short term (\[SMD (95% CI) = 0.15 (−0.00, 0.31), P = 0.06\] ([Table 3](#t3){ref-type="table"}, [Supplementary Figure S3](#S1){ref-type="supplementary-material"}) and mid term \[SMD (95% CI) = 0.05 (−0.24, 0.34), P = 0.73\] ([Table 3](#t3){ref-type="table"}, [Supplementary Figure S4](#S1){ref-type="supplementary-material"}). A sensitivity analysis was performed for the total SF-36 score, the SF-36 physical function subscale, the SF-36 mental health subscale, the SF-36 general health subscale, the significance of the results was not changed when studies were removed one by one.

### General Health Questionnaire (GHQ)

Two studies[@b22][@b57] were included to estimate the effect of TCE on the GHQ. The TCE group outperformed the control group in terms of improving the GHQ in a random effects model \[SMD (95% CI) = −0.68 (−1.26, −0.09), P = 0.02\] ([Table 3](#t3){ref-type="table"}).

### WHO quality of life (WHOQOL)

The meta-analysis of four studies[@b23][@b31][@b53][@b60] with 287 patients that were suitable for inclusion revealed that TCE had a significant positive effect on the WHOQOL general health subscale \[SMD (95% CI) = 0.68 (0.04, 0.47), P = 0.04\]. However, TCE did not have a significant effect on the WHOQOL physical health subscale \[SMD (95% CI) = 0.13 (−0.59, 0.85), P = 0.73\] or the WHOQOL psychological health subscale \[SMD (95% CI) = 0.22 (−0.04, 0.47), P = 0.09\] ([Table 3](#t3){ref-type="table"}). The results were affected by one study[@b60] for WHOQOL general health, one study[@b53] for WHOQOL physical health, and one study[@b53] for WHOQOL psychological health in the sensitivity analysis. Therefore, the meta analysis provided weak evidence of the effects of TCE on the WHOQOL.

Depression
----------

### Center for Epidemiologic Studies Depression Scale (CES-D)

Eight studies[@b24][@b25][@b51][@b55][@b56][@b58][@b69][@b78] with 508 patients were included to estimate the effect of TCE on the CES-D. TCE could improve the CES-D in the short term \[SMD (95% CI) = −0.86 (−1.42, −0.31), P = 0.002\] ([Table 3](#t3){ref-type="table"} and [Fig. 4A](#f4){ref-type="fig"}) and mid term \[SMD (95% CI) = −0.41 (−0.64, −0.18), P \< 0.001\] ([Table 3](#t3){ref-type="table"} and [Fig. 4B](#f4){ref-type="fig"}). Sensitivity analysis revealed that the pooled result was stable when studies were removed one by one.

### Self-rating depression scale (SDS)

The meta-analysis of five studies[@b30][@b33][@b40][@b72][@b75] with 315 patients that were suitable for inclusion found that TCE had a significant effect on the SDS in the short term \[SMD (95% CI) = −0.6 (−0.83, −0.36), P \< 0.001\] ([Table 3](#t3){ref-type="table"}, [Supplementary Figure S5 A](#S1){ref-type="supplementary-material"}). Sensitivity analysis found that the pooled result was not influenced by individual trials.

### Beck Depression Inventory (BDI)

Three studies[@b26][@b31][@b43] with data from 180 patients were included to assess the effect of TCE on the BDI. TCE had a non-significant positive effect on the BDI in a random effects model \[SMD (95% CI) = −0.15 (−0.75, 0.44), P = 0.61\] ([Table 3](#t3){ref-type="table"}). The significance of the result was changed in the sensitivity analysis when one study[@b26] was removed, this result offered inferior evidence for the effect of TCE on BDI.

### Profile of Mood States-Depression (POMS-D)

Three studies[@b68][@b70][@b71] with data from 156 patients were used to estimate the effect of TCE on the POMS-D. TCE could improve the POMS-D in the short term (SMD (95% CI) = −1.64 (−2.55, −0.73), P \< 0.001) ([Table 3](#t3){ref-type="table"}, [Supplementary Figure S5 B](#S1){ref-type="supplementary-material"}). Sensitivity analysis indicated that the pooled result was not influenced by individual trials.

### Hamilton Depression Scale (HAMD)

The meta-analysis of three studies[@b37][@b61][@b73] with 189 patients that were suitable for inclusion indicated that TCE had a significant effect on the HAMD in the short term \[SMD (95% CI) = −1.36 (−1.97, −0.75), P \< 0.001\] ([Table 3](#t3){ref-type="table"}, [Supplementary Figure S5 C](#S1){ref-type="supplementary-material"}). Sensitivity analysis revealed that the pooled result was stable when studies were removed one by one.

### Symptom Checklist-90 (SCL-90)

Four studies[@b21][@b38][@b74][@b77] presenting data from 284 patients were included to assess the effect of TCE on the SCL-90. The result showed that TCE improved the SCL-90 \[SMD (95% CI) = −0.7 (−1.32, −0.08), P = 0.03\] ([Table 3](#t3){ref-type="table"}). Sensitivity analysis indicated that the pooled result was not influenced by individual trials.

Publication bias
----------------

The results of the Egger's regression test did not reveal any publication bias for the total SF-36 (asymmetry test P = 0.128), SF-36 physical function (asymmetry test P = 0.207), the SF-36 mental health subscale (asymmetry test P = 0.678), the SF-36 general health subscale (asymmetry test P = 0.906), and the CES-D (asymmetry test P = 0.361).

Discussion
==========

Summary of findings
-------------------

Several types of TCE are used to prevent and treat chronic diseases. However, the extant systematic reviews primarily focus on either one type of disease (e.g., cardiovascular disease) or one type of TCE (e.g., Tai Chi). In this review and meta-analysis, we combined all of the evidence from the numerous relevant studies evaluating the various forms of TCE into one review to assess the overall effect of TCE on patients with chronic diseases.

We gathered information on 4311 subjects from 60 articles that provided evidence on the effects of TCE on improving the quality of life and alleviating depression in patients with chronic diseases. The meta-analysis revealed that TCE had a significant positive effect on the quality of life (SF-36 physical function, SF-36 mental health, SF-36 total, GHQ, and WHOQOL general health) and depression (CES-D, SDS, POMS-D, HMAD, SCL-90) in patients with chronic diseases. Therefore, TCE had a significant clinical effect on improving the quality of life and reducing depression in patients with chronic diseases. We used the chi-square test and I^2^ statistic to assess the heterogeneity among the studies, and identified obvious heterogeneity for some outcomes. To solve this problem, sensitivity analysis was conducted for to assess the consistency and quality of the results. Sensitivity analysis revealed that most of the pooled results (SF-36, CES-D, SDS, POMS-D, HAMD, SCL-90) were stable when studies were removed one by one. But the significance of the result (WHOQOL, BDI) was changed through sensitivity analysis, these results offered inferior evidence for the effect of TCE on WHOQOL and BDI.Because TCE does not require the use of equipment, the exercises are low in cost and easy to learn. Chronic patients who performed TCE demonstrated considerable improvements in their conditions[@b80][@b81]. According to the theory of Traditional Chinese medicine, TCE could help one's body to dredge the meridians and collaterals, facilitate blood circulation, relax the mind, balance emotion, and regulate the internal organs to enhance one's physical health and quality of life and to improve one's psychological state[@b6]. TCE generally combines postural control, breath regulation and mediation. The primary benefit of TCE stems from the holistic nature, and TCE benefits both physical and psychosocial health. However, the exact mechanism by which TCE affects patients with chronic diseases is complex and remains unclear. Thus, further evidence on the mechanism by which TCE affect chronic diseases should be obtained.

Strengths and limitations
-------------------------

Relevant articles were searched from a wide range of electronic databases (e.g., PubMed, EMBASE, Web of Science, and Cochrane Library). Considering that TCE originated in China, we searched for relevant information from the largest Chinese information database. The current study was the first meta-analysis to estimate the effects of TCE on the quality of life and depression of patients with chronic diseases by comparing an intervention group with a no intervention group. Given that the selected articles were published in America, Asia, Europe, and Oceania, the results of this study may be generalizable to most parts of the world. Furthermore, most of the included articles were published over the last five years (from 2010 to 2015). To reduce bias and transcription errors, two authors independently performed the study selection, data extraction, and quality assessment processes.

Nevertheless, our meta-analysis had several limitations. First, although all of the included articles were RCTs, only 15 studies (25%) reported how the patient allocation was concealed. According to the intention-to-treat principle, 13 articles (21.67%) used the intention to treat as their primary analysis method. A total of 23 articles (38.33%) blinded the outcome assessors to the treatment allocation. Second, the outcome assessors could not be blinded for the comparison between the TCE group and the no-intervention group, therefore generating potential performance and response biass. Third, most articles had no long-term follow-up period (over one year). Therefore, we did not conduct a meta-analysis to estimate the long-term effect of TCE on chronic diseases. Fourth, we used Egger's regression test to assess publication bias. Additionally, we systematically searched several electronic databases for publications. Although we found no publication bias, we did not search for any unpublished trials. Fifth, due to the lack of studies with training time ranging from 6 months to 12 months, especially 12 months, we did not perform a subgroup meta analysis focusing on exercise training time. Sixth, some studies included in our meta analysis had small sample sizes. Future meta-analyses including more large-scale, high-quality RCTs are required to obtain further proof of the effects of TCE. Seventh, most of the Chinese studies from our meta analysis were not registered in the international clinical trials registry platform of the World Health Organization. To reduce bias, all studies should be performed in accordance with the standards of clinical trials (e.g., the Consolidated Standards of Reporting Trials statement).

Implications for policy and practice
------------------------------------

Traditional medicine/exercise, including TCE is an important and often underestimated part of health services worldwide[@b82]. TCE is extensively performed in most countries; however, in many countries and regions, the public, medical professionals, and healthcare policymakers remain confused about the effectiveness, safety, and quality of TCE. In our meta-analysis, we identified both the scientific and clinical importance of TCE. Unlike other exercises, TCE may contribute to improving the quality of life (e.g., SF-36 and GHQ) and reducing depression (e.g., CESD, SDS, BDI) in patients with chronic diseases. These findings provide useful information for chronic disease patients, medical professionals, and healthcare policymakers. As public health professionals, we believe that healthcare policymakers and medical professionals must consider how TCE improves the health of patients with chronic diseases.

Implications and future research
--------------------------------

Further evidence from larger and better quality studies must be collected to determine the effects of TCE on chronic diseases. Most of the articles with small sample sizes that were included in our meta-analysis only observed patients over a short-term follow-up period. Multicenter RCTs with large sample sizes must be conducted to validate the effects of TCE in patients with chronic diseases. Future studies should improve their methodological standards in the following aspects: random allocation, allocation concealment, long-term follow-up, intention-to-treat analysis, and assessor blinding. Likewise, such studies should adhere to generally accepted standards for reporting clinical trials (e.g., the Consolidated Standards of Reporting Trials statement). To estimate the duration of TCE-induced improvements, long-term follow-up periods must be adopted in future studies. In addition, the long-term effectiveness of TCE for patients with chronic diseases must be estimated.
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###### Characteristics of included studies.

  Article,Year                   Country/region  Participant Characteristic,Sample Size                                                                                                                Disease                                                                    Intervention/comparisongroups                                       Duration oftrial period                                                                    Outcomes                                         Timepoint
  ----------------------------- ---------------- ----------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------------------------------ ------------------------------------------------ -----------------------------------------
  An (2008) [@b20]                   China       28 subjects (G1 = 14, G2 = 14). Mean age(SD): G1 = 65.4 y (8.2), G2 = 64.6 y (6.7)                                                                    Musculoskeletal disorder (Knee osteoarthritis)                             G1: Baduanjin G2: No intervention                                   Five times a week for 8 weeks                                                              Quality of life (SF-36)                          8 weeks
  Barrow (2007) [@b21]                 UK        65 subjects (G1 = 32, G2 = 33). Mean age: G1 = 68.4 y, G2 = 67.9 y                                                                                    Cardiovascular diseases (Heart failure)                                    G1: Tai Chi G2: Usual care                                          Twice a week for 16 weeks                                                                  Depression (SCL-90)                              16 weeks
  Blake (2009) [@b22]                  UK        20 subjects (G1 = 10, G2 = 10). Mean age(SD): G1 = 46.2 y (11.27), G2 = 44.5 y (10.52)                                                                Cardiovascular and cerebrovascular diseases (Brain injury)                 G1: Tai Chi + Qigong G2: No intervention                            Once a week for 8 weeks                                                                    Quality of life (GHQ)                            8 weeks
  Cai (2010) [@b23]                  China       60 subjects (G1 = 30, G2 = 30). Mean age(SD): G1 = 60.3 y (10.5), G2 = 61.3 y (7.4).                                                                  Cardiovascular and cerebrovascular diseases (Stroke)                       G1: Baduanjin exercise + usual care G2: Usual care                  Four or five times a week for 3 months                                                     Quality of life (WHO QOL)                        3 months
  Chen (2008) [@b24]                  USA        162subjects(G1 = 57, G2 = 49) Mean age(SD): G1 = 61.3 y(8.4)G2 = 62.9 y(9.2)                                                                          Musculoskeletal disorder (Knee osteoarthritis)                             G1: Qigong G2: Sham Qigong                                          Five or six sessions a week for 3 weeks                                                    Depression (CES-D)                               3 weeks 15 weeks
  Chen (2013) [@b25]                  USA        96 subjects (G1 = 49, G2 = 47). Mean age(SD): G1 = 45.3 y(6.3), G2 = 44.7 y(9.7),                                                                     Cancer (Breast cancer)                                                     G1: Qigong G2: Wait-list                                            Five times a week for 6 weeks                                                              Depression (CES-D)                               6 weeks 10 weeks 18 weeks
  Cheung (2005) [@b26]             Hong Kong     88 subjects (G1 = 47, G2 = 41). Mean age(SD): G1 = 57.2 y (9.5), G2 = 51.2 y (7.4)                                                                    Cardiovascular and cerebrovascular diseases (Hypertension)                 G1: Qigong G2: Conventional exercise                                Twice a week for 4 weeks                                                                   Quality of life (SF-36), depressing (CES-D)      4 weeks 8 weeks 16 weeks
  Chyu (2010) [@b27]                  USA        61 subjects (G1 = 30, G2 = 31). Mean age(SD): G1 = 72.4 y (6.2), G2 = 71.3 y (6)                                                                      Musculoskeletal disorder (Osteopaenia)                                     G1: Tai Chi G2: No intervention                                     Three times a week for 24 weeks                                                            Quality of life (SF-36)                          12 weeks 24 weeks
  Fransen (2007) [@b28]            Australia     152 subjects (G1 = 56, G2 = 55, G3 = 41). Mean age(SD): G1 = 70.8 y (6.3), G2 = 70 y (6.3), G3 = 69.6 y (6.1)                                         Musculoskeletal disorder (Osteoarthritis)                                  G1: Tai Chi 2: HydrotherapyG3: No intervention                      Twice a week for 12 weeks                                                                  Quality of life (SF-12)                          6 weeks 12 weeks
  Gemmell (2006) [@b29]           New Zealand    18 subjects (G1 = 9, G2 = 9).                                                                                                                         Cardiovascular and cerebrovascular diseases (Traumatic brain injury)       G1: Tai Chi G2: No intervention                                     Once a week for 6 weeks                                                                    Quality of life (SF-36)                          6 weeks
  Guan (2012) [@b30]                 China       80 subjects (G1 = 39, G2 = 40).Mean age(SD): G1 = 59.2 y (8.8), G2 = 58.7 y (8.3).                                                                    Diabetes                                                                   G1: Baduanjin + conventional treatment G2: Conventional treatment   Seven times a week for 4 months                                                            Depression (SDS)                                 4 months
  Haak (2008) [@b31]                 Sweden      57subjects(G1 = 29,G2 = 28) Mean age(SD): G1 = 54.0 y(9.4) G2 = 53.4 y(8.0)                                                                           Musculoskeletal disorder (Fibromyalgia Syndrome)                           G1: Qigong G2: Waiting-list                                         7 weeks                                                                                    Quality of life (WHOQOL), Depression (BDI)       4 months
  Hart (2004) [@b32]                 Israel      152 subjects (G1 = 56, G2 = 55, G3 = 41). Mean age(SD): G1 = 70.8 y (6.3), G2 = 70 y (6.3), G3 = 69.6 y (6.1)                                         Cardiovascular and cerebrovascular diseases (Stroke)                       G1: Tai Chi G2: Hydrotherapy G3: No intervention                    Twice a week for 12 weeks                                                                  Quality of life (Duke Health Profile)            6 weeks 12 weeks
  Ji (2012) [@b33]                   China       62 subjects (G1 = 32, G2 = 30). Mean age(SD): G1 = 60.31 y(7.23), G2 = 60.26 y(7.15)                                                                  Diabetes                                                                   G1: Baduanjin + drug G2: Drug                                       Once a day for 2 months                                                                    Depression (SDS)                                 2 months
  Lam (2008) [@b34]                Australia     53 subjects (G1 = 28, G2 = 25). Mean age(SD): G1 = 63.2 y (8.6), G2 = 60.7 y (12.2)                                                                   Diabetes (Type 2 diabetes)                                                 G1: Tai Chi G3: No exercise                                         Twice a week for 6 months                                                                  Quality of life (SF-36)                          6 months
  Lee 2009) [@b35]                   Korea       44 subjects (G1 = 29, G2 = 15). Mean age(SD): G1 = 70.2 y (4.8), G2 = 66.9 y (6)                                                                      Musculoskeletal disorder (Osteoarthritis)                                  G1: Tai Chi and Qigong G2: No intervention                          Twice a week for 8 weeks                                                                   Quality of life (SF-36)                          8 weeks
  Li (2010) [@b36]                   China       60 subjects (G1 = 30, G2 = 30). Age over 45 y                                                                                                         Musculoskeletal disorder (Osteoporosis)                                    G1: Tai Chi + usual care G2: Usual care                             Once a day for 12 months                                                                   Quality of life (SF-36)                          12 months
  Li (2012) [@b37]                   China       68 subjects (G1 = 36, G2 = 32). Age range: 38 to 76 y                                                                                                 Cardiovascular and cerebrovascular diseases (Stroke)                       G1: Tai Chi G2: Conventional exercise                               Twice a week for 5 weeks                                                                   Depression (HAMD)                                5 weeks
  Li (2012) [@b38]                   China       70 subjects (G1 = 35, G2 = 35). Mean age(SD): G1 = 72.0 y (2.5), G2 = 73.0 y (3.0)                                                                    Chronic respiratory diseases (COPD)                                        G1: Tai Chi + respiratory exercise G2: Respiratory exercise         Once a day for 6 months                                                                    Depression (SCL-90)                              6 months
  Li (2013) [@b39]                   China       216 subjects (G1 = 54, G2 = 54, G3 = 54, G4 = 54). Mean age(SD): G1 = 50.42 y (9.68), G2 = 51.62 y (7.83), G3 = 54.21 y (9.47), G4 = 52.69 y (8.37)   Diabetes                                                                   G1: Baduanjin G2: Aerobic exercise G3: Tai Chi G4: Control          Once a day for 3 months                                                                    Quality of life (SF-36)                          3 months 9 months
  Liu (2012) [@b40]                  China       69 subjects (G1 = 33, G2 = 36). Mean age(SD): G1 = 62.64 y (5.98), G2 = 65.64 y (8.38),                                                               Diabetes                                                                   G1: Baduanjin + education G2: Education                             Once a week for 12 weeks                                                                   Depression (SDS)                                 6 weeks 12 weeks
  Liu (2013) [@b41]                Australia     41 subjects (G1 = 20, G2 = 21). Mean age(SD): G1 = 59 y (8), G2 = 59 y (8)                                                                            Diabetes                                                                   G1: Tai Chi G2: Usual medical-care                                  Three sessions per week for 12 weeks                                                       Quality of life (SF-36)                          12 weeks
  Ng (2011) [@b42]                 Hong Kong     80 subjects (G1 = 40, G2 = 40). Mean age(SD): G1 = 71.75 y (1.05), G2 = 73.12 y (1.33)                                                                Chronic respiratory diseases (COPD)                                        G1: Qigong G2: Conventional treatment                               Four times a week for 6 month                                                              Quality of life (SF-36)                          3 months 6 months
  Putiri (2012) [@b43]                USA        32 subjects (G1 = 11, G2 = 11, G3 = 10). Mean age(SD): G1 = 57.0 y (6.3), G2 = 58.4 y (7.4), G3 = 59.4 y (6.8)                                        Diabetes (Type 2 diabetes)                                                 G1: Qigong G2: Resistance training G3: Usual care                   At least twice a week for 12 weeks                                                         Depression (BDI)                                 12 weeks
  Rendant (2011) [@b44]             Germany      122 subjects (G1 = 42, G2 = 39, G3 = 41). Mean age(SD): G1 = 44.7 y (10.8), G2 = 44.4 y (10.9), G3 = 47.8 y (10.3)                                    Musculoskeletal disorder (Chronic neck pain)                               G1: Qigong G2: Conventional exercise G3: Waiting List               1 session per week in the first 3 months, and biweeklysessions in the following 3 months   Quality of life (SF-36)                          3 months 6 months
  Robins (2013) [@b45]                USA        145 subjects. aged 27--75 years                                                                                                                       Cancer (Breast cancer)                                                     G1: Tai Chi G2: Usual medical-care                                  90 minutes each week for a total of 10 weeks                                               Depression (CES-D)                               3 months 4.5 months 6 months
  Shen(2010) [@b46]                   USA        171 subjects (G1 = 42, G2 = 38, G3 = 44, G4 = 47). Mean age(SD): G1 = 58.3y(7.7), G2 = 57.6y(6.7), G3 = 57.6 y (7.5), G4 = 56.5 y (5.5)               Musculoskeletal disorder (Postmenopausal osteopenic women)                 G1: Tai Chi + Placebo G2: Tai Chi + drug G3: Placebo G4: Drug       Three sessions a week for 12 weeks                                                         Quality of life (SF-36)                          8 weeks 12 weeks 16 weeks 24 weeks
  Singh-Grewal (2007) [@b47]         Canada      80 subjects (G1 = 41, G2 = 39). Mean age(SD): G1 = 11.7y (2.5), G2 = 11.5y (2.4)                                                                      Musculoskeletal disorder (Arthritis)                                       G1: Qigong G2: Aerobic training                                     Three times a week for 12-week                                                             Quality of life (HRQOL)                          12 weeks
  Skoglund (2011) [@b48]             Sweden      37 subjects. Age range: 42 to 54 y                                                                                                                    Musculoskeletal disorder (Neck-shoulder pain)                              G1: Qigong G2: No Intervention                                      Four times a week for six weeks                                                            Quality of life (SF-12)                          6 weeks
  Sprod (2012) [@b49]                 USA        65 subjects (G1 = 32, G2 = 33). Mean age: G1 = 68.4 y, G2 = 67.9 y                                                                                    Cancer (Breast cancer)                                                     G1: Tai Chi G2: Usual care                                          Three times a week for 12 weeks                                                            Quality of life (SF-36)                          12 weeks
  Stephens (2008) [@b50]             Canada      30 subjects (G1 = 16, G2 = 14). Mean age(SD): G1 = 12.9 y(2.7), G2 = 13.6 y(1.8)                                                                      Musculoskeletal disorder (Fibromyalgia)                                    G1: Qigong G2: Aerobic training                                     Three times a week for 12 weeks                                                            Depression (Chinldhood depression inventory)     12 weeks
  Taylor-Piliae (2012) [@b51]         USA        20 subjects (G1 = 10, G2 = 10). Mean age(SD): G1 = 46.2 y (11.27), G2 = 44.5 y (10.52)                                                                Cardiovascular and cerebrovascular diseases (Chronic stroke)               G1: Tai Chi G2: Usual care                                          Once a week for 8 weeks                                                                    Quality of life (SF-36), depressing (CES-D)      8 weeks
  Trott (2009) [@b52]               Germany      117 subjects (G1 = 38, G2 = 39, G3 = 40). Mean age(SD): G1 = 75.9 y(7.6), G2 = 76.0 y(7.2) G3 = 75.7 y(7.6)                                           Musculoskeletal disorder (Chronic neck pain)                               G1: Qigong G2: General exercise G3: Wait-list                       2 sessions a week for 3 months                                                             Quality of life(SF-36)                           3 months 6 months
  Tsang (2003) [@b53]              Hong Kong     50 subjects (G1 = 24, G2 = 26). Mean age(SD): G1 = 72.93 y(9.53), G2 = 76.27 y(8.40)                                                                  Chronic physical illnesses                                                 G1: Qigong G2: Usual care                                           Twice a week for 12-week                                                                   Quality of life (WHOQOL)                         6 weeks 12 weeks
  Tsang (2007) [@b54]              Australia     38 subjects (G1 = 18, G2 = 20). Mean age(SD): G1 = 66 y (8), G2 = 65 y (8)                                                                            Diabetes                                                                   G1: Tai Chi G2: Sham Tai Chi                                        Twice a week for 16 weeks                                                                  Quality of life (SF-36)                          16 weeks
  Wang (2008) [@b55]                  USA        20 subjects (G1 = 10, G2 = 10). Mean age(SD): G1 = 48 y (10), G2 = 51 y (17)                                                                          Musculoskeletal disorder (Rheumatoid arthritis)                            G1: Tai Chi G2: Stretching + education                              Twice a week for 12 weeks                                                                  Quality of life (SF-36), depressing (CES-D)      12 weeks
  Wang (2010) [@b56]                  USA        66 subjects (G1 = 33, G2 = 33). Mean age(SD): G1 = 49.7 y (11.8), G2 = 50.5 y (10.5)                                                                  Musculoskeletal disorder (fibromyalgia)                                    G1: Tai Chi G2: Stretching + education                              Twice a week for 12 weeks                                                                  Quality of life (SF-36), depressing (CES-D)      12 weeks 24 weeks
  Wang (2010) [@b57]                 Japan       34 subjects (G1 = 17, G2 = 17). Mean age(SD): G1 = y (), G2 = y ()                                                                                    Cardiovascular and cerebrovascular diseases (Cerebral vascular disorder)   G1: Tai Chi G2: General exercise                                    Once a week for 12 weeks                                                                   Quality of life (GHQ)                            12 weeks
  Wang (2009) [@b58]                  USA        40 subjects (G1 = 20, G2 = 20). Mean age(SD): G1 = 63 y (8.1), G2 = 68 y (7.0)                                                                        Musculoskeletal disorder (Knee osteoarthritis)                             G1: Tai Chi G2: Stretching + education                              Twice a week for 12 weeks                                                                  Quality of life(SF-36),depression (CES-D)        12 weeks 24 weeks 48 weeks
  Wang (2009) [@b59]                 China       64 subjects (G1 = 34, G2 = 30). Mean age(SD): G1 = 48.24 y (10.06), G2 = 47.86 y (11.12)                                                              Diabetes (Type 2 diabetes)                                                 G1: Tai Chi + drug G2: Drug                                         Five or seven times a week for 6 months                                                    Quality of life (SF-36)                          6 months
  Wang (2010) [@b60]                 China       120 subjects (G1 = 58, G2 = 62). Age range: 28--65 y                                                                                                  Cancer (Breast cancer)                                                     G1: Tai Chi G2: Conventional exercise                               Twice a day for 170 days                                                                   Quality of life (WHOQ OL)                        170 days
  Wang (2012)[@b61]                  China       69 subjects (G1 = 36, G2 = 33). Mean age(SD): G1 = 55.8 y (3.54), G2 = 51.2 y (7.8)                                                                   Cardiovascular and cerebrovascular diseases (Stroke)                       G1: Tai Chi G2: Conventional exercise                               Twice a week for 3 months                                                                  Depression (HAMD)                                6 months
  Wang (2013) [@b62]                 China       60 subjects (G1 = 30, G2 = 30). Mean age(SD): G1 = 55.25 y (11.13), G2 = 54.86 y (12.05)                                                              Cardiovascular and cerebrovascular diseases                                G1: Tai Chi + usual care G2: Usual care                             Five times a week for 6 months                                                             Quality of life (SF-36)                          3 months 6 months
  Wayne (2012) [@b63]                 USA        86 subjects (G1 = 43, G2 = 43). Mean age(SD): G1 = 58.8 y (5.6), G2 = 60.4 y (5.3)                                                                    Musculoskeletal disorder (Post-menopausal osteopenic)                      G1: Tai Chi exercise G2: Usual care                                 99.5 hours over the 9 month                                                                Quality of life (SF-36)                          12 weeks
  Wei (2014) [@b64]                  China       60 subjects (G1 = 20, G2 = 20, G3 = 20). Mean age(SD): G1 = 63.9y (7.6), G2 = 64.8y (5.8), G3 = 65.3 y (6.0)                                          Diabetes (Type 2 diabetes)                                                 G1: Baduanjin G2: Walking G3: Control                               Five times a week for 3 months                                                             Quality of life (SF-36)                          3 months
  Wenneberg (2004) [@b65]            Sweden      31 subjects (G1 = 16, G2 = 15).                                                                                                                       Musculoskeletal disorder (Muscular dystrophy)                              G1: Qigong G2: No intervention                                      Once a week for two months                                                                 Quality of life (SF-36)                          2 months
  Wu (1999) [@b66]                    USA        22 subjects (G1 = 11, G2 = 11). Mean age(SD): G1 = 37.8 y(11.7), G2 = 39.3 y(13.2)                                                                    Musculoskeletal disorder (Pain syndrome type 1)                            G1: Qigong G2: Sham Qigong                                          Twice a week for 3 weeks, everyday for the following 7 weeks                               Depression (BDI)                                 1 weeks 3 weeks 6 weeks 10 weeks
  Wu (2012) [@b67]                   China       52 subjects (G1 = 26, G2 = 26). Mean age(SD): G1 = 55.92 y (9.25), G2 = 56.46 y (9.13).                                                               Musculoskeletal disorder (Low back pain)                                   G1: Baduanjin + electrotherapy G2: Electrotherapy                   Four or five times a week for 1 month                                                      Quality of life (SF-36)                          1 month
  Yang (2005) [@b68]                 Korea       43 subjects (G1 = 20, G2 = 23). Mean age(SD): G1 = 72.58 y (5.41), G2 = 72.67 y (7.49)                                                                Musculoskeletal disorder (Chronic pain)                                    G1: Qi gong exercise G2: Usual care                                 Twice a week for four weeks                                                                Depression (POMS)                                1 weeks 2 weeks 3 weeks 4 weeks 6 weeks
  Yeh (2010) [@b69]                   USA        10 subjects (G1 = 5, G2 = 5). Mean age(SD): G1 = 65 y (6), G2 = 66 y (6)                                                                              Chronic respiratory diseases (COPD)                                        G1: Tai Chi + usual care G2: Usual care                             Twice a week for 12 weeks                                                                  Depression (CES-D)                               12 weeks
  Yeh (2011) [@b70]                   USA        100 subjects (G1 = 50, G2 = 50). Mean age(SD): G1 = 68.1 y (11.9), G2 = 66.6 y (12.1)                                                                 Cardiovascular and cerebrovascular diseases (Chronic heart failure)        G1: Tai Chi G2: Education                                           Twice a week for 12 weeks                                                                  Depression (POMS-D)                              12 weeks
  Yeh (2013) [@b71]                   USA        16 subjects (G1 = 8, G2 = 8). Mean age(SD): G1 = 68 y (11), G2 = 63 y (11)                                                                            Cardiovascular and cerebrovascular diseases (Heart failure)                G1: Tai Chi G2: Aerobic exercise                                    Twice a week for 12 weeks                                                                  Depression (POMS-D)                              12 weeks
  Zhou (2014) [@b72]                 China       25 subjects (G1 = 13, G2 = 12). Age range: 58-80 y                                                                                                    Diabetes                                                                   G1: Qigong G2: Education                                            Once a week for 12 weeks                                                                   Depression (SDS)                                 12 weeks
  Wang (2014) [@b73]                 China       60 subjects (G1 = 30, G2 = 30). Mean age(SD): G1 = 72.9 y (9.09), G2 = 71.1 y (8.4)                                                                   Chronic respiratory diseases (COPD)                                        G1: Liuzijue G2: Conventional therapy                               Seven times a week for 12 weeks                                                            Depression (HAMD)                                12 weeks
  Wang (2014) [@b74]                 China       70 subjects (G1 = 35, G2 = 35). Mean age(SD): G1 = 67.8 y (6.6), G2 = 68.0 y (7.5)                                                                    Diabetes (Type 2 diabetes)                                                 G1: Taichi G2: Conventional therapy                                 Five times a week for 8 weeks                                                              Depression (SCL-90)                              8 weeks
  Sun (2014) [@b75]                  China       80 subjects (G1 = 38, G2 = 42). Mean age(SD): G1 = 68.1 y (4.4), G2 = 69.1 y (4.2)                                                                    Cardiovascular and cerebrovascular diseases                                G1: Taichi G2: Education                                            Seven times a week for 8 weeks                                                             Depression (SDS)                                 8 weeks
  Meng (2014) [@b76]                 China       200 subjects (G1 = 100, G2 = 100). Age range: 60--89 year                                                                                             Diabetes (Type 2 diabetes)                                                 G1: Taichi G2: Conventional exercise                                Four times a week for 12 weeks                                                             Quality of life (SF-36)                          8 weeks
  Fang (2014) [@b77]                 China       89 subjects (G1 = 30, G2 = 29, G3 = 30). Mean age(SD): G1 = 56.6 y (8.85), G2 = 58.2 y (8.9), G3 = 57.1 y (9.2)                                       Diabetes                                                                   G1: Qigong + education G2: Walk + educationG3: Education            Five times a week for 12 weeks                                                             Depression (SCL-90)                              12 weeks
  Taylor (2014) [@b78]                USA        145 subjects (G1 = 53, G2 = 44, G3 = 48). Mean age(SD): G1 = 71.5 y (10.3), G2 = 69.6 y (9.4), G3 = 68.2 y (10.3)                                     Cardiovascular and cerebrovascular diseases (Stroke)                       G1: Tai Chi G2: Strength exercise G3: Usual care                    Three times a week for 12 weeks                                                            Quality of life (SF-36) and depression (CES-D)   12 weeks
  Park (2014) [@b79]                 Korea       40 subjects (G1 = 19, G2 = 21). Mean age(range): G1 = 52 y (43--61), G2 = 54 y (45--62)                                                               Cardiovascular and cerebrovascular diseases                                G1: Qigong G2: No intervention                                      Three times a week for 8 weeks                                                             Quality of life (SF-36)                          4 weeks 8 weeks

BDI: Beck Depression Inventory, CES-D: Center for Epidemiologic Studies Depression Scale, COPD: Chronic obstructive pulmonary disease, GHQ: General Health Questionnaire, HAMD: Hamilton Depression Scale, POMS-D: Profile of Mood States-Depression, SCL-90: Symptom Checklist 90, SDS: Self-rating depression scale, SF-36: Short-form 36, WHOQOL: World Health Organization Quality of Life.

###### Risk of bias assessment of included studies.

  Article(Year)                  Randomallocation   Concealedallocation   Baselinecomparability   Blindsubjects   Blindtherapists   Blindassessors   Adequatefollow-up   Intention totreat analysis   Between-groupcomparisons   Point estimatesand variability
  ----------------------------- ------------------ --------------------- ----------------------- --------------- ----------------- ---------------- ------------------- ---------------------------- -------------------------- --------------------------------
  An (2008) [@b20]                     Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Barrow (2007) [@b21]                 Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Blake (2009) [@b22]                  Yes                  No                     Yes                 No               No                No                Yes                     Yes                         Yes                           Yes
  Cai (2010) [@b23]                    Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Chen (2008) [@b24]                   Yes                  No                     Yes                 No               No               Yes                No                      Yes                         Yes                           Yes
  Chen (2013) [@b25]                   Yes                  No                     Yes                 No               No                No                Yes                      No                         Yes                           Yes
  Cheung (2005) [@b26]                 Yes                  No                     Yes                 No               No                No                No                      Yes                         Yes                           Yes
  Chyu (2010) [@b27]                   Yes                  No                     Yes                 No               No               Yes                Yes                      No                         Yes                           Yes
  Fransen (2007) [@b28]                Yes                  Yes                    Yes                 No               No               Yes                Yes                     Yes                         Yes                           Yes
  Gemmell (2006) [@b29]                Yes                  No                     Yes                 No               No               Yes                No                       No                         Yes                           Yes
  Guan (2012) [@b30]                   Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Haak (2008) [@b31]                   Yes                  No                     Yes                 No               No                No                Yes                      No                         Yes                           Yes
  Hart (2004) [@b32]                   Yes                  No                     No                  No               No               Yes                No                       No                         Yes                           Yes
  Ji (2012) [@b33]                     Yes                  No                     Yes                 No               No               Yes                No                       No                         Yes                           Yes
  Lam (2008) [@b34]                    Yes                  No                     Yes                 No               No               Yes                Yes                      No                         Yes                           Yes
  Lee (2009) [@b35]                    Yes                  Yes                    Yes                 No               No               Yes                Yes                     Yes                         Yes                           Yes
  Li (2010) [@b36]                     Yes                  No                     No                  No               No                No                No                       No                         Yes                           Yes
  Li (2012) [@b37]                     Yes                  No                     Yes                 No               No               Yes                No                       No                         Yes                           Yes
  Li (2012) [@b38]                     Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Li (2013) [@b39]                     Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Liu (2012) [@b40]                    Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Liu (2013) [@b41]                    Yes                  No                     No                  No               No                No                No                      Yes                         Yes                           Yes
  Ng (2011) [@b42]                     Yes                  Yes                    Yes                 No               No               Yes                No                      Yes                         Yes                           Yes
  Putiri (2012) [@b43]                 Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Rendant (2011) [@b44]                Yes                  Yes                    Yes                 No               No                No                Yes                     Yes                         Yes                           Yes
  Robins (2013) [@b45]                 yes                  No                     Yes                 No               No                No                Yes                      No                         Yes                           Yes
  Shen (2010) [@b46]                   Yes                  No                     Yes                 No               No               Yes                Yes                     Yes                         Yes                           Yes
  Singh-Grewal (2007) [@b47]           Yes                  Yes                    Yes                 No               No               Yes                Yes                     Yes                         Yes                           Yes
  Skoglund (2011) [@b48]               Yes                  No                     Yes                 No               No                No                Yes                      No                         Yes                           Yes
  Sprod (2012) [@b49]                  Yes                  Yes                    Yes                 No               No                No                No                       No                         Yes                           Yes
  Stephens (2008) [@b50]               Yes                  Yes                    Yes                 No               No               Yes                No                      Yes                         Yes                           Yes
  Taylor-Piliae (2012) [@b51]          Yes                  Yes                    Yes                 No               No               Yes                Yes                      No                         Yes                           Yes
  Trott (2009) [@b52]                  Yes                  No                     Yes                 No               No                No                No                      Yes                         Yes                           Yes
  Tsang (2003) [@b53]                  Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Tsang (2007) [@b54]                  Yes                  Yes                    Yes                 No               No                No                Yes                     Yes                         Yes                           Yes
  Wang (2008) [@b55]                   Yes                  Yes                    Yes                 No               No               Yes                Yes                     Yes                         Yes                           Yes
  Wang (2010) [@b56]                   Yes                  Yes                    Yes                 No               No                No                Yes                     Yes                         Yes                           Yes
  Wang (2010) [@b57]                   Yes                  No                     Yes                 No               No               Yes                Yes                     Yes                         Yes                           Yes
  Wang (2009) [@b58]                   Yes                  Yes                    Yes                 No               No                No                Yes                     Yes                         Yes                           Yes
  Wang (2009) [@b59]                   Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Wang (2010) [@b60]                   Yes                  No                     Yes                 No               No                No                Yes                      No                         Yes                           Yes
  Wang (2012)[@b61]                    Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Wang (2013) [@b62]                   Yes                  No                     Yes                 No               No                No                Yes                      No                         Yes                           Yes
  Wayne (2012) [@b63]                  Yes                  No                     Yes                 No               No               Yes                Yes                     Yes                         Yes                           Yes
  Wei (2014) [@b64]                    Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Wenneberg (2004) [@b65]              Yes                  No                     Yes                 No               No               Yes                Yes                      No                         Yes                           Yes
  Wu (1999) [@b66]                     Yes                  No                     Yes                 No               No                No                Yes                      No                         Yes                           Yes
  Wu (2012) [@b67]                     Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Yang (2005) [@b68]                   Yes                  No                     Yes                 No               No                No                Yes                      No                         Yes                           Yes
  Yeh (2010) [@b69]                    Yes                  No                     Yes                 No               No               Yes                Yes                     Yes                         Yes                           Yes
  Yeh (2011) [@b70]                    Yes                  No                     Yes                 No               No               Yes                Yes                     Yes                         Yes                           Yes
  Yeh (2013) [@b71]                    Yes                  No                     Yes                 No               No               Yes                No                      Yes                         Yes                           Yes
  Zhou (2014) [@b72]                   Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Wang (2014) [@b73]                   Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Wang (2014) [@b74]                   Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Sun (2014) [@b75]                    Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Meng (2014) [@b76]                   Yes                  No                     Yes                 No               No                No                No                       No                         Yes                           Yes
  Fang (2014) [@b77]                   Yes                  Yes                    Yes                 No               No                No                No                       No                         Yes                           Yes
  Taylor (2014) [@b78]                 Yes                  Yes                    Yes                 No               No               Yes                No                      Yes                         Yes                           Yes
  Park (2014) [@b79]                   Yes                  Yes                    Yes                 No               No               Yes                Yes                      No                         Yes                           Yes

###### Summary of results.

  Outcome                                                                                  Trials                                                           Participants              Statistical Method                  Effect Estimate      Heterogeneity   P value
  -------------------------------- ----------------------------------------------------------------------------------------------------------------------- -------------- ------------------------------------------- ------------------------ --------------- ---------
  Short term                                                                                                                                                                                                                                                   
   Quality of life                                                                                                                                                                                                                                             
    SF-36 total                                                            6 [@b35][@b39][@b49][@b62][@b67][@b76]                                               591        Std. Mean Difference (IV, Random, 95% CI)    0.59 \[0.32, 0.87\]    0.05            \<0.001
    SF-36 physical function         19 [@b27][@b29][@b35][@b41][@b44][@b46][@b49][@b51][@b52][@b54][@b55][@b56][@b58][@b63][@b64][@b65][@b76][@b78][@b79]       1332       Std. Mean Difference (IV, Random, 95% CI)    0.35 \[0.13, 0.56\]    \<0.001         0.002
    SF-36 mental health             19 [@b20][@b27][@b29][@b35][@b44][@b46][@b49][@b51][@b52][@b54][@b55][@b56][@b58][@b63][@b64][@b65][@b76][@b78][@b79]       1312       Std. Mean Difference (IV, Random, 95% CI)    0.28 \[0.11, 0.46\]    \<0.001         0.002
    SF-36 general health                                    11 [@b20][@b27][@b29][@b41][@b46][@b49][@b54][@b55][@b65][@b76][@b79]                               648        Std. Mean Difference (IV, Random, 95% CI)    0.15 \[−0.00, 0.31\]   0.66            0.06
    GHQ                                                                                2 [@b22][@b57]                                                            49        Std. Mean Difference (IV, Random, 95% CI)   −0.68 \[−1.26, −0.09\]  0.73            0.02
    WHO-QOL physical health                                                      4 [@b23][@b31][@b53][@b60]                                                     287        Std. Mean Difference (IV, Random, 95% CI)    0.13 \[−0.59, 0.85\]   \<0.001         0.73
    WHO-QOL psychological health                                                 4 [@b23][@b31][@b53][@b60]                                                     287        Std. Mean Difference (IV, Random, 95% CI)    0.22 \[−0.04, 0.47\]   0.32            0.09
    WHO-QOL general health                                                       4 [@b23][@b31][@b53][@b60]                                                     287        Std. Mean Difference (IV, Random, 95% CI)    0.68 \[0.04, 1.32\]    \<0.001         0.04
  Depression                                                                                                                                                                                                                                                   
   CES-D                                                             8 [@b24][@b25][@b51][@b55][@b56][@b58][@b69][@b78]                                         508        Std. Mean Difference (IV, Random, 95% CI)   −0.86 \[−1.42, −0.31\]  \<0.001         0.002
   SDS                                                                        5 [@b30][@b33][@b40][@b72][@b75]                                                  315        Std. Mean Difference (IV, Random, 95% CI)   −0.6 \[−0.83, −0.36\]   0.37            \<0.001
   BDI                                                                              3 [@b26][@b31][@b43]                                                        180        Std. Mean Difference (IV, Random, 96% CI)   −0.15 \[−0.75, 0.44\]   0.03            0.61
   POMS                                                                             3 [@b68][@b70][@b71]                                                        156        Std. Mean Difference (IV, Random, 95% CI)   −1.64 \[−2.55, −0.73\]  \<0.001         \<0.001
   HAMD                                                                             3 [@b37][@b61][@b73]                                                        189        Std. Mean Difference (IV, Random, 96% CI)   −1.36 \[−1.97, −0.75\]  0.03            \<0.001
  Mid term                                                                                                                                                                                                                                                     
   Quality of life                                                                                                                                                                                                                                             
    SF-36 total                                                                        2 [@b39][@b62]                                                           276        Std. Mean Difference (IV, Random, 95% CI)    0.61 \[0.16, 1.05\]    0.12            0.008
    SF-36 physical function                                       9 [@b26][@b27][@b34][@b44][@b46][@b52][@b56][@b58][@b59]                                      771        Std. Mean Difference (IV, Random, 95% CI)    0.49 \[0.12, 0.85\]    \<0.001         0.009
    SF-36 mental health                                        10 [@b27][@b34][@b42][@b44][@b46][@b52][@b56][@b58][@b59][@b63]                                  846        Std. Mean Difference (IV, Random, 95% CI)    0.39 \[0.08, 0.71\]    \<0.001         0.02
    SF-36 general health                                                7 [@b26][@b27][@b34][@b42][@b46][@b59][@b63]                                            592        Std. Mean Difference (IV, Random, 95% CI)    0.05 \[−0.24, 0.34\]   0.007           0.73
  Depression                                                                                                                                                                                                                                                   
   CES-D                                                                         4 [@b24][@b25][@b56][@b58]                                                     308        Std. Mean Difference (IV, Random, 95% CI)   −0.41 \[−0.64, −0.18\]  0.78            \<0.001
   SCL-90                                                                        4 [@b21][@b28][@b74][@b77]                                                     284        Std. Mean Difference (IV, Random, 95% CI)   −0.7 \[−1.32, −0.08\]   \<0.001         0.03

BDI: Beck Depression Inventory, CES-D: Center for Epidemiologic Studies Depression Scale, GHQ: General Health Questionnaire, HAMD: Hamilton Depression Scale, POMS-D: Profile of Mood States-Depression, SCL-90: Symptom Checklist 90, SDS: Self-rating depression scale, SF-36: Short-form 36, WHOQOL: World Health Organization Quality of Life.

[^1]: These authors contributed equally to this work.
